COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia

Not Applicable

Completed

Conditions: Vulvar Intraepithelial Neoplasia (VIN)

Interventions: Device: CO2 Laser Ablation
Device: Sonopet Ultrasonic Aspirator

First Posted Date: 2016-08-23

Last Posted Date: 2023-11-18

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 47

Registration Number: NCT02875561

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
🇺🇸
University of Oklahoma, Norman, Oklahoma, United States

Prospective Identification of Long QT Syndrome in Fetal Life

Completed

Conditions: Long QT Syndrome

First Posted Date: 2016-08-23

Last Posted Date: 2022-02-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 25

Registration Number: NCT02876380

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: FOLFIRINOX or gemcitabine/abraxane
Radiation: SBRT

First Posted Date: 2016-08-19

Last Posted Date: 2022-12-19

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 14

Registration Number: NCT02873598

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage

Completed

Conditions: Subarachnoid Hemorrhage

Interventions: Other: Pharmacokinetic modeling

First Posted Date: 2016-08-15

Last Posted Date: 2024-04-02

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 15

Registration Number: NCT02866877

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

The Crnic Institute Human Trisome Project Biobank

Recruiting

Conditions: Trisomy 21
Down Syndrome

First Posted Date: 2016-08-11

Last Posted Date: 2024-04-02

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 2500

Registration Number: NCT02864108

Locations: 🇺🇸
Linda Crnic Institute for Down Syndrome at the University of Colorado Denver, Denver, Colorado, United States

Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants?

Phase 4

Completed

Conditions: Hypospadias
Urethrocutaneous Fistula

Interventions: Drug: Caudal block with ropivacaine
Drug: penile nerve block with bupivacaine

First Posted Date: 2016-08-10

Last Posted Date: 2024-07-01

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 165

Registration Number: NCT02861950

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Impact of Transcranial Direct Current Stimulation on Fatigability and Fatigue Induced by a Selective Attention Task

Phase 1

Withdrawn

Conditions: Fatigue

Interventions: Device: transcranial direct current stimulation
Device: sham tDCS

First Posted Date: 2016-07-21

Last Posted Date: 2017-07-02

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT02840214

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis

Not Applicable

Terminated

Conditions: Bronchiolitis

Interventions: Drug: 3% Nebulized Hypertonic Saline

First Posted Date: 2016-07-15

Last Posted Date: 2020-02-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 18

Registration Number: NCT02834819

Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal

Phase 4

Withdrawn

Conditions: Alcohol Withdrawal

Interventions: Drug: Ketamine
Drug: Dexmedetomidine
Drug: Normal saline

First Posted Date: 2016-07-06

Last Posted Date: 2018-01-19

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT02823977

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Drug: cannabidiol

First Posted Date: 2016-06-30

Last Posted Date: 2019-02-19

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 13

Registration Number: NCT02818777

Locations: 🇺🇸
University of Colorado School of Medicine, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy